Skip to Content

NovelStem International Corp NSTM

Rating as of

Morningstar’s Analysis

Valuation
Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

NovelStem International Corp is focused on developing a diagnostic technology that can predict patients' resistance to chemotherapy.

Contact
2255 Glades Road, Suite 221A
Boca Raton, FL, 33431
T +1 561 998-8000
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Sep 30, 2013
Fiscal Year End Dec 31, 2013
Stock Type Slow Growth
Employees 15